Conmed (CNMD) Equity Ratio (2016 - 2025)
Historic Equity Ratio for Conmed (CNMD) over the last 16 years, with Q4 2025 value amounting to 0.44.
- Conmed's Equity Ratio rose 641.47% to 0.44 in Q4 2025 from the same period last year, while for Dec 2025 it was 0.44, marking a year-over-year increase of 641.47%. This contributed to the annual value of 0.44 for FY2025, which is 641.47% up from last year.
- Latest data reveals that Conmed reported Equity Ratio of 0.44 as of Q4 2025, which was up 641.47% from 0.43 recorded in Q3 2025.
- In the past 5 years, Conmed's Equity Ratio registered a high of 0.44 during Q4 2021, and its lowest value of 0.31 during Q3 2022.
- In the last 5 years, Conmed's Equity Ratio had a median value of 0.41 in 2021 and averaged 0.39.
- In the last 5 years, Conmed's Equity Ratio tumbled by 2745.51% in 2022 and then skyrocketed by 1767.03% in 2024.
- Conmed's Equity Ratio (Quarter) stood at 0.44 in 2021, then dropped by 27.04% to 0.32 in 2022, then grew by 11.78% to 0.36 in 2023, then rose by 15.09% to 0.42 in 2024, then increased by 6.41% to 0.44 in 2025.
- Its Equity Ratio was 0.44 in Q4 2025, compared to 0.43 in Q3 2025 and 0.43 in Q2 2025.